Anti-B7-H3 (TAA06 biosimilar) mAb (HDBS0162)
- SKU:
- HDBS0162
- Antibody Type:
- Biosimilar Reference Antibody
- Applications:
- IHC
- FC
- Drug Development
- Pharmacokinetics
- Disease Area:
- Cancer Immunotherapy
- Disease Area:
- Tumor Microenvironment
- Size:
- 100 μg
- Target:
- B7-H3
- Isotype:
- IgG1
- Host Species:
- Humanized
- Reactivity:
- Human
Description
| Product Name: | Anti-B7-H3 (TAA06 biosimilar) mAb |
| SKU: | HDBS0162 |
| Size: | 100 μg |
| Target: | B7-H3 |
| Common Name: | TAA06 |
| Isotype: | IgG1 |
| Host Species: | Humanized |
| Reactivity: | Human |
| Synonyms: | B7H3, CD276, B7 homolog 3 |
| Applications: | ELISA Flow Cyt |
| Recommended Dilutions: | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Conjugate: | Unconjugated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
| Uniprot: | Q5ZPR3 |
| Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Usage: | Research use only |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature. |
Related Products
Enoblituzumab Biosimilar (Anti-B7-H3) Antibody (HDBS0010)
€399